Found 17 results
Author [ Title(Desc)] Type Year
Filters: Author is Smith, C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
S. Vasan, Schlesinger, S., Huang, Y., Hurley, A., Lombardo, A., Chen, Z., Than, S., Adesanya, P., Bunce, C., Boaz, M., Boyle, R., Sayeed, E., Clark, L., Dugin, D., Schmidt, C., Song, Y., Seamons, L., Dally, L., Ho, M., Smith, C., Markowitz, M., Cox, J., Gill, D., and Gilmour, J., Phase 1 Safety and Immunogenicity Evaluation of ADVAX a Multigenic, DNA-Based Clade C/B’ HIV-1 Candidate Vaccine, PLoS ONE, vol. 5, p. e8617, 2010.
B. Peters, Jaoko, W., Anzala, O., Judges, L., G Manyonyi, O., Sharp, A., Gray, K., Fast, P., Schmidt, C., Gilmour, J., Smith, C., Dally, L., Loughran, K., Farah, B., Tarragona, T., Hayes, P., McMichael, A., Hanke, T., and Bwayo, J., Phase 2A Dose and Route Study of a DNA Prime MVA Boost Vaccine Candidate, in AIDS Vaccine 2005 International Conference, Montreal, Quebec, Canada, 2005.
I. Cebere, Dorrell, L., McShane, H., Simmons, A., McCormack, S., Schmidt, C., Smith, C., Brooks, M., Roberts, J. E., Darwin, S. C., Fast, P. E., Conlon, C., Rowland-Jones, S., McMichael, A. J., and Hanke, T., Phase I Clinical Trial Safety of DNA- and Modified Virus Ankara-Vectored Human Immunodeficiency Virus Type 1 (HIV-1) Vaccines Administered Alone and in a Prime-Boost Regime to healthy HIV-1 Uninfected Volunteers, Vaccine, vol. 24, pp. 417-425, 2006.
D. B. Kaufman, III, G. W. Burke, Bruce, D. S., Johnson, C. P., Gaber, A. O., Sutherland, D. E. R., Merion, R. M., Gruber, S. A., Schweitzer, E., Leone, J. P., Marsh, C. L., Alfrey, E., Concepcion, W., Stegall, M. D., Schulak, J. A., Gores, P. F., Benedetti, E., Smith, C., Henning, A. K., Kuehnel, F., and , A prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation, American Journal of Transplantation, vol. 3, pp. 855-64, 2003.
S
B. Rivoire, Groathouse, N., TerLouw, S., K Neupane, D., Ranjit, C., B Sapkota, R., Khadge, S., Kunwar, C., Macdonald, M., Hawksworth, R., Thapa, M., Hagge, D., Tibbals, M., Smith, C., Dube, T., She, D., Wolff, M., ,, Sizemore, C., and Brennan, P., Safety and Efficacy Assessment of Two New Leprosy Skin Test Antigens: Randomized Double Blind Clinical Study, PLOS Neglected Tropical Diseases, vol. 8, p. e2811, 2014.
F. Nakwagala, Birungi, J., Schmidt, C., Nanvubya, A., Konde, C., Hughes, P., Mugisha, E., Johnson, B., Muluubya, A., Nielsen, L., Gilmour, J., Gibiansky, L., Smith, C., Fast, P., and Kaleebu, P., Safety and immunogenicity of HIV-1 clade A vaccines in healthy, HIV uninfected adult Ugandan volunteers, 2004.
E. Vardas, Pantaleo, G., Bart, P. A., Robinson, A., Pieterse, C., Thomas, R., McIntyre, J., Gray, G., Bogoshi, M., Mayaphi, S., Fast, P., Schmidt, C., Gilmour, J., Tarragona, T., Smith, C., and Dally, L., Safety and Immunogenicity of MVA.HIVA by 3 Different Routes, in AIDS Vaccine 2005 International Conference, Montreal, Quebec, Canada, 2005.
J. W, FN, N., O, A., G, O. Manyonyi, J, B., A, N., F, B., K, B., H, O., S, W., L, M., W, W., J, O., M, O., J, I., J, N. - A., C, K., ,, Smith, C., Barin, B., Dally, L., ,, and Kaleebu, P., Safety and Immunogenicity of Recombinant Low-Dosage HIV-1 A Vaccine Candidates Vectored by Plasmid pTHr DNA or Modified Vaccinia Virus Ankara (MVA) in Humans in East Africa, Vaccine, vol. 26, pp. 2788-2795, 2008.
W. Jaoko, Kayitenkore, K., G Manyonyi, O., Karita, E., Schmidt, C., Fast, P., Komaroff, W., Cooper, A., Boaz, M., Gilmour, J., Dally, L., Ho, M., Smith, C., and Graham, B., Safety and Immunogenicity of VRC Multiclade HIV-1 Adenoviral Vector Vaccine Alone or with VRC Multiclade HIV-1 DNA Plasmid Vaccine in the African Adults, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
W. Jaoko, Karita, E., Kayitenkore, K., Omosa-Manyonyi, G., Allen, S., Than, S., Adams, E., Graham, B., Koup, R., Bailer, R., Smith, C., Dally, L., Farah, B., Anzala, O., Muvunyi, C., Bizimana, J., Tarragona-Fiol, T., Bergin, P., Hayes, P., Ho, M., Loughran, K., and Komaroff, W., Safety and Immunogenicity Study of Multiclade HIV-1 Adeno-Viral Vector Vaccine Alone or as Boost Following a Multiclade HIV-1 DNA Vaccine in Africa, PLoS ONE, vol. 5, p. e12873, 2010.